Amedeo's Top 20

Amedeo Smart

Independent Medical Education


09 May 2022

Multidisciplinary Journal Club

  1. Davidson KW, Barry MJ, Mangione CM, Cabana M, et al.
    Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
    JAMA 2022;327:1577-1584.

  1. Arbel R, Sergienko R, Friger M, Peretz A, et al.
    Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years.
    Nat Med 2022.

  2. Wetmore JB, Weinhandl ED, Yan H, Reyes JL, et al.
    Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study.
    Am J Kidney Dis 2022.

  3. Rotstein D, Solomon JM, Sormani MP, Montalban X, et al.
    Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
    Neurology 2022.

  4. LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, et al.
    The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int 2022.

  1. Podell BK, Aibana O, Huang CC, DiLisio JE, et al.
    The Impact of Vitamin A Deficiency on Tuberculosis Progression.
    Clin Infect Dis 2022.

  2. Sandborn WJ, D'Haens GR, Reinisch W, Panes J, et al.
    Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
    Gastroenterology 2022;162:1650-1664.e8.

  3. Miller PD, Adachi JD, Albergaria BH, Cheung AM, et al.
    Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.
    J Bone Miner Res 2022.

  4. Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, et al.
    Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.
    Am J Psychiatry 2022;179:132-141.

  5. Whitwell J, Martin PR, Graff-Radford J, Machulda M, et al.
    Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease.
    Neurology 2022.

  1. Mozaffarian D.
    Obesity - an unexplained epidemic.
    Am J Clin Nutr 2022.

  2. Park DY, Tom MC, Chen Y, Tewari S, et al.
    Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomas.
    J Neurooncol 2022.

  3. Podda M, Pisanu A, Morello A, Segalini E, et al.
    Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg 2022;109:319-331.

  4. Heshmatollah A, Fani L, Koudstaal PJ, Ghanbari M, et al.
    Plasma Amyloid Beta, Total-Tau and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study.
    Neurology 2022.

  5. Vig SJ, Garza J, Tao Y.
    The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review.
    Headache 2022.

  1. van Etten ES, Kaushik K, Jolink WMT, Koemans EA, et al.
    Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study.
    Stroke 2022;53:1692-1699.

  2. Eisenach JC.
    Gadgeteering for Pain Relief: The 2021 John W. Severinghaus Lecture on Translational Science.
    Anesthesiology 2022.

  3. Tuttle KR, Levin A, Nangaku M, Kadowaki T, et al.
    Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials.
    Diabetes Care 2022.

  4. Ducharme MP, Scarsi C, Bettazzi E, Mautone G, et al.
    A NOVEL LEVOTHYROXINE SOLUTION RESULTS IN SIMILAR BIOAVAILABILITY WHETHER TAKEN 30 OR JUST 15 MINUTES BEFORE A HIGH-FAT HIGH- CALORIC MEAL.
    Thyroid 2022.

  5. Zhong W, Yan S, Chen Z, Luo Z, et al.
    Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarction.
    J Neurol Neurosurg Psychiatry 2022.


more..


Privacy Policy